Industry News Zepbound single-dose vials price lowered   Imfinzi approved as first and only perioperative immunotherapy for patients with early gastric and gastroesophageal cancers Dupixent approved as the first targeted medicine for chronic spontaneous urticaria in the EU AbbVie set to present phase 3 ECLIPSE data highlighting atogepant superiority over placebo   Bayer begins phase III study with long-acting reversible intrauterine system for treatment of nonatypical endometrial hyperplasia An Overview of Recent USP Bacterial Endotoxins Standards Development Regeneron and Tessera Therapeutics set to develop TSRA-196 for alpha-1 antitrypsin deficiency Bayer’s Asundexian meets primary efficacy and safety endpoints in phase III OCEANIC-STROKE study   Roche receives FDA clearance for its point-of-care test for diagnosing Bordetella infections Strategies for Controlling the Quality of mRNA Sonrotoclax granted priority review by the U.S. FDA for the treatment of relapsed or refractory mantle cell lymphoma Novo Nordisk files for approval of a higher dose of Wegovy injection 7.2 mg Upcoming Webinars